1. Home
  2. MWA vs ACAD Comparison

MWA vs ACAD Comparison

Compare MWA & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MUELLER WATER PRODUCTS

MWA

MUELLER WATER PRODUCTS

HOLD

Current Price

$30.26

Market Cap

4.4B

Sector

Industrials

ML Signal

HOLD

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$21.87

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MWA
ACAD
Founded
1857
1993
Country
United States
United States
Employees
3500
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.9B
IPO Year
2006
2000

Fundamental Metrics

Financial Performance
Metric
MWA
ACAD
Price
$30.26
$21.87
Analyst Decision
Buy
Buy
Analyst Count
2
22
Target Price
$30.50
$30.55
AVG Volume (30 Days)
788.5K
1.7M
Earning Date
05-04-2026
05-06-2026
Dividend Yield
0.92%
N/A
EPS Growth
64.86
69.12
EPS
0.27
2.30
Revenue
$1,429,700,000.00
$726,437,000.00
Revenue This Year
$4.85
$18.90
Revenue Next Year
$4.20
$11.62
P/E Ratio
$112.69
$9.33
Revenue Growth
8.75
40.45
52 Week Low
$22.74
$14.08
52 Week High
$31.00
$28.35

Technical Indicators

Market Signals
Indicator
MWA
ACAD
Relative Strength Index (RSI) 66.28 48.71
Support Level $26.66 $20.22
Resistance Level $30.74 $22.03
Average True Range (ATR) 0.76 0.73
MACD 0.34 0.11
Stochastic Oscillator 89.20 55.86

Price Performance

Historical Comparison
MWA
ACAD

About MWA MUELLER WATER PRODUCTS

Mueller Water Products Inc is a U.S.-based company that manufactures and sells products and services used in the transmission, distribution, and measurement of water. The company operates in two segments: Water Flow Solutions and Water Management Solutions. The Water Flow Solutions segment, which derives maximum revenue for the company, includes products like iron gate valves, specialty valves, and service brass products. Water Management Solutions' portfolio includes fire hydrants, repair and installation, natural gas, metering, leak detection, and pressure management and control products and solutions. Geographically, the company derives a majority of its revenue from the United States and the rest from Canada and other international locations.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

Share on Social Networks: